{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:03:55Z","timestamp":1787162635288,"version":"build-2736575974"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Recurrence is still a major obstacle to the successful treatment of gliomas. Understanding the underlying mechanisms of recurrence may help for developing new drugs to combat gliomas recurrence. This study provides a strategy to discover new drugs for recurrent gliomas based on drug perturbation induced gene expression changes.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    The RNA-seq data of 511 low grade gliomas primary tumor samples (LGG-P), 18 low grade gliomas recurrent tumor samples (LGG-R), 155 glioblastoma multiforme primary tumor samples (GBM-P), and 13 glioblastoma multiforme recurrent tumor samples (GBM-R) were downloaded from TCGA database. DESeq2, key driver analysis and weighted gene correlation network analysis (WGCNA) were conducted to identify differentially expressed genes (DEGs), key driver genes and coexpression networks between LGG-P\n                    <jats:italic>vs<\/jats:italic>\n                    LGG-R, GBM-P\n                    <jats:italic>vs<\/jats:italic>\n                    GBM-R pairs. Then, the CREEDS database was used to find potential drugs that could reverse the DEGs and key drivers.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    We identified 75 upregulated and 130 downregulated genes between LGG-P and LGG-R samples, which were mainly enriched in human papillomavirus (HPV) infection, PI3K-Akt signaling pathway, Wnt signaling pathway, and ECM-receptor interaction. A total of 262 key driver genes were obtained with frizzled class receptor 8 (\n                    <jats:italic>FZD8<\/jats:italic>\n                    ), guanine nucleotide-binding protein subunit gamma-12 (\n                    <jats:italic>GNG12<\/jats:italic>\n                    ), and G protein subunit \u03b22 (\n                    <jats:italic>GNB2<\/jats:italic>\n                    ) as the top hub genes. By screening the CREEDS database, we got 4 drugs (Paclitaxel, 6-benzyladenine, Erlotinib, Cidofovir) that could downregulate the expression of up-regulated genes and 5 drugs (Fenofibrate, Oxaliplatin, Bilirubin, Nutlins, Valproic acid) that could upregulate the expression of down-regulated genes. These drugs may have a potential in combating recurrence of gliomas.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    We proposed a time-saving strategy based on drug perturbation induced gene expression changes to find new drugs that may have a potential to treat recurrent gliomas.\n                  <\/jats:p>","DOI":"10.3389\/fgene.2021.832627","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T01:37:38Z","timestamp":1642383458000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["A Computational Framework to Identify Biomarkers for Glioma Recurrence and Potential Drugs Targeting Them"],"prefix":"10.3389","volume":"12","author":[{"given":"Shuzhi","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Size","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-1632","article-title":"Successful Use of Cidofovir in an Immunocompetent Child with Severe Adenoviral Sepsis","volume":"145","author":"Alcamo","year":"2020","journal-title":"Pediatrics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1007\/s00415-009-5167-6","article-title":"Very Late Relapses in Glioblastoma Long-Term Survivors","volume":"256","author":"B\u00e4hr","year":"2009","journal-title":"J. Neurol."},{"key":"B3","first-page":"3579","article-title":"Bioinformatics Analysis of miRNA Expression Profile between Primary and Recurrent Glioblastoma","volume":"19","author":"Bo","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B4","first-page":"13","article-title":"FZD8 Indicates a Poor Prognosis and Promotes Gastric Cancer Invasion and Metastasis via B-Catenin Signaling Pathway","volume":"50","author":"Chen","year":"2020","journal-title":"Ann. Clin. Lab. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e1006418","DOI":"10.1371\/journal.pcbi.1006418","article-title":"MDHGI: Matrix Decomposition and Heterogeneous Graph Inference for miRNA-Disease Association Prediction","volume":"14","author":"Chen","year":"2018","journal-title":"Plos Comput. Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.biomaterials.2018.01.053","article-title":"Hacking Macrophage-Associated Immunosuppression for Regulating Glioblastoma Angiogenesis","volume":"161","author":"Cui","year":"2018","journal-title":"Biomaterials"},{"key":"B7","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s00066-015-0858-7","article-title":"Wnt\/\u03b2-catenin Pathway Involvement in Ionizing Radiation-Induced Invasion of U87 Glioblastoma Cells","volume":"191","author":"Dong","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.1200\/jco.2008.19.8721","article-title":"Bevacizumab Alone and in Combination with Irinotecan in Recurrent Glioblastoma","volume":"27","author":"Friedman","year":"2009","journal-title":"Jco"},{"key":"B9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.path.2021.05.003","article-title":"Molecular Pathology of Gliomas","volume":"14","author":"Galbraith","year":"2021","journal-title":"Surg. Pathol. Clin."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0181346","DOI":"10.1371\/journal.pone.0181346","article-title":"Wnt\/\u03b2-catenin Signaling Pathway Inhibits the Proliferation and Apoptosis of U87 Glioma Cells via Different Mechanisms","volume":"12","author":"Gao","year":"2017","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1200\/jco.2007.11.5964","article-title":"Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation with Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity","volume":"26","author":"Hegi","year":"2008","journal-title":"Jco"},{"key":"B12","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1136\/thoraxjnl-2020-214756","article-title":"Genetically Raised Serum Bilirubin Levels and Lung Cancer: a Cohort Study and Mendelian Randomisation Using UK Biobank","volume":"75","author":"Horsfall","year":"2020","journal-title":"Thorax"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1097\/wnr.0000000000001156","article-title":"Hypoxia Enhances the Migration and Invasion of Human Glioblastoma U87 Cells through PI3K\/Akt\/mTOR\/HIF-1\u03b1 Pathway","volume":"29","author":"Huang","year":"2018","journal-title":"Neuroreport"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.2174\/138161210791033932","article-title":"Nutlins and Ionizing Radiation in Cancer Therapy","volume":"16","author":"Impicciatore","year":"2010","journal-title":"Cpd"},{"key":"B15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.1239947","article-title":"Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma","volume":"343","author":"Johnson","year":"2014","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1073\/pnas.1303607110","article-title":"TERT Promoter Mutations Occur Frequently in Gliomas and a Subset of Tumors Derived from Cells with Low Rates of Self-Renewal","volume":"110","author":"Killela","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.nano.2014.09.005","article-title":"A Tumor-Targeting P53 Nanodelivery System Limits Chemoresistance to Temozolomide Prolonging Survival in a Mouse Model of Glioblastoma Multiforme","volume":"11","author":"Kim","year":"2015","journal-title":"Nanomedicine: Nanotechnology, Biol. Med."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13071053","article-title":"Glioblastoma Multiforme-A Look at the Past and a Glance at the Future","volume":"13","author":"King","year":"2021","journal-title":"Pharmaceutics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1200\/jco.2008.16.3055","article-title":"Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma","volume":"27","author":"Kreisl","year":"2009","journal-title":"Jco"},{"key":"B20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00011-009-0062-2","article-title":"Gng12 Is a Novel Negative Regulator of LPS-Induced Inflammation in the Microglial Cell Line BV-2","volume":"59","author":"Larson","year":"2010","journal-title":"Inflamm. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/labinvest.2015.140","article-title":"WNT Signaling in Glioblastoma and Therapeutic Opportunities","volume":"96","author":"Lee","year":"2016","journal-title":"Lab. Invest."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1038\/s41598-018-22022-4","article-title":"Radiosensitization Effect of Talazoparib, a Parp Inhibitor, on Glioblastoma Stem Cells Exposed to Low and High Linear Energy Transfer Radiation","volume":"8","author":"Lesueur","year":"2018","journal-title":"Sci. Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/2211-5463.12784","article-title":"GNG12 Regulates PD\u2010L1 Expression by Activating NF\u2010\u03baB Signaling in Pancreatic Ductal Adenocarcinoma","volume":"10","author":"Li","year":"2020","journal-title":"FEBS Open Bio"},{"key":"B24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.canlet.2017.05.029","article-title":"FZD8, a Target of P53, Promotes Bone Metastasis in Prostate Cancer by Activating Canonical Wnt\/\u03b2-Catenin Signaling","volume":"402","author":"Li","year":"2017","journal-title":"Cancer Lett."},{"key":"B25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12876-021-01643-6","article-title":"Expression and Prognostic Impact of FZDs in Pancreatic Adenocarcinoma","volume":"21","author":"Li","year":"2021","journal-title":"BMC Gastroenterol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.7150\/jca.24488","article-title":"Anticancer Properties of Fenofibrate: A Repurposing Use","volume":"9","author":"Lian","year":"2018","journal-title":"J. Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.omtn.2020.07.003","article-title":"An Improved Anticancer Drug-Response Prediction Based on an Ensemble Method Integrating Matrix Completion and Ridge Regression","volume":"21","author":"Liu","year":"2020","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"B28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fbioe.2020.00131","article-title":"Identifying Small Molecule-miRNA Associations Based on Credible Negative Sample Selection and Random Walk","volume":"8","author":"Liu","year":"","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.2147\/ott.s199196","article-title":"miRNA-99b-5p Targets FZD8 to Inhibit Non-small Cell Lung Cancer Proliferation, Migration and Invasion","volume":"12","author":"Liu","year":"2019","journal-title":"Ott"},{"key":"B30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fgene.2020.00147","article-title":"Fragment Enrichment of Circulating Tumor DNA with Low-Frequency Mutations","volume":"11","author":"Liu","year":"","journal-title":"Front. Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"22811","DOI":"10.1038\/srep22811","article-title":"A Systematic Study on Drug-Response Associated Genes Using Baseline Gene Expressions of the Cancer Cell Line Encyclopedia","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a Summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1002\/cncr.32986","article-title":"Cancer Attributable to Human Papillomavirus Infection in China: Burden and Trends","volume":"126","author":"Lu","year":"2020","journal-title":"Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.bbapap.2018.08.013","article-title":"Proteomic Analyses Reveal GNG12 Regulates Cell Growth and Casein Synthesis by Activating the Leu-Mediated mTORC1 Signaling Pathway","volume":"1866","author":"Luo","year":"2018","journal-title":"Biochim. Biophys. Acta (Bba) - Proteins Proteomics"},{"key":"B35","doi-asserted-by":"publisher","first-page":"102112","DOI":"10.1016\/j.ctrv.2020.102112","article-title":"Oxaliplatin Retreatment in Metastatic Colorectal Cancer: Systematic Review and Future Research Opportunities","volume":"91","author":"Mauri","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.2174\/138161207782360528","article-title":"Valproic Acid as Anti-cancer Drug","volume":"13","author":"Michaelis","year":"2007","journal-title":"Cpd"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1073\/pnas.0914356107","article-title":"Mutant EGFR Is Required for Maintenance of Glioma Growth In Vivo, and its Ablation Leads to Escape from Receptor Dependence","volume":"107","author":"Mukasa","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ceb.2014.01.005","article-title":"Novel Insights into G Protein and G Protein-Coupled Receptor Signaling in Cancer","volume":"27","author":"O'hayre","year":"2014","journal-title":"Curr. Opin. Cel Biol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","article-title":"CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012","author":"Ostrom","year":"","journal-title":"Neuro Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-12048-5_1","article-title":"Epidemiology of Gliomas","volume":"163","author":"Ostrom","year":"","journal-title":"Cancer Treat. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00438-018-1438-1","article-title":"HNMDA: Heterogeneous Network-Based miRNA-Disease Association Prediction","volume":"293","author":"Peng","year":"20182018","journal-title":"Mol. Genet. Genomics"},{"key":"B42","first-page":"14722","article-title":"Prioritizing Antiviral Drugs against SARS-CoV-2 by Integrating Viral Complete Genome Sequences and Drug Chemical Structures. Scientific reportsImmunologic Escape after Prolonged Progression-free Survival with Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients with Newly Diagnosed Glioblastoma","volume":"1128","author":"Peng","year":"20212010","journal-title":"J. Clin. Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3389\/fgene.2020.577387","article-title":"Identifying Effective Antiviral Drugs against SARS-CoV-2 by Drug Repositioning through Virus-Drug Association Prediction[J]","volume":"11","author":"Peng","year":"2020","journal-title":"Front. Genet."},{"key":"B44","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12967-019-1846-y","article-title":"Longitudinal Heterogeneity in Glioblastoma: Moving Targets in Recurrent versus Primary Tumors","volume":"17","author":"Sch\u00e4fer","year":"2019","journal-title":"J. Transl Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12916-020-01703-w","article-title":"Circulating Bilirubin Levels and Risk of Colorectal Cancer: Serological and Mendelian Randomization Analyses","volume":"18","author":"Seyed Khoei","year":"2020","journal-title":"BMC Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.2174\/1381612826666200131100630","article-title":"Wnt\/beta-catenin and PI3K\/Akt\/mTOR Signaling Pathways in Glioblastoma: Two Main Targets for Drug Design: A Review","volume":"26","author":"Shahcheraghi","year":"2020","journal-title":"Cpd"},{"key":"B47","doi-asserted-by":"publisher","first-page":"603615","DOI":"10.3389\/fimmu.2020.603615","article-title":"Indicator Regularized Non-negative Matrix Factorization Method-Based Drug Repurposing for COVID-19","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"12846","DOI":"10.1038\/ncomms12846","article-title":"Extraction and Analysis of Signatures from the Gene Expression Omnibus by the Crowd","volume":"7","author":"Wang","year":"2016","journal-title":"Nat. Commun."},{"key":"B49","doi-asserted-by":"publisher","first-page":"105780","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma Multiforme (GBM): An Overview of Current Therapies and Mechanisms of Resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020263","article-title":"Molecular Network-Based Drug Prediction in Thyroid Cancer","volume":"20","author":"Xu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3389\/fgene.2020.00253","article-title":"Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme","volume":"11","author":"Yang","year":"","journal-title":"Front. Genet."},{"key":"B52","doi-asserted-by":"publisher","first-page":"32566","DOI":"10.1038\/srep32566","article-title":"Discover the Network Mechanisms Underlying the Connections between Aging and Age-Related Diseases","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11357-019-00106-x","article-title":"Human Geroprotector Discovery by Targeting the Converging Subnetworks of Aging and Age-Related Diseases","volume":"42","author":"Yang","year":"","journal-title":"Geroscience"},{"key":"B54","doi-asserted-by":"publisher","first-page":"78989","DOI":"10.18632\/oncotarget.20742","article-title":"Frizzled 8 Promotes the Cell Proliferation and Metastasis of Renal Cell Carcinoma","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"B55","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1158\/1535-7163.mct-12-1090","article-title":"Tumor-initiating Cells and FZD8 Play a Major Role in Drug Resistance in Triple-Negative Breast Cancer","volume":"12","author":"Yin","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nm.3751","article-title":"Mutations in G Protein \u03b2 Subunits Promote Transformation and Kinase Inhibitor Resistance","volume":"21","author":"Yoda","year":"2015","journal-title":"Nat. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"758845","DOI":"10.3389\/fimmu.2021.758845","article-title":"Low GNG12 Expression Predicts Adverse Outcomes: A Potential Therapeutic Target for Osteosarcoma","volume":"12","author":"Yuan","year":"2021","journal-title":"Front. Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s12539-021-00458-z","article-title":"Using Network Distance Analysis to Predict lncRNA-miRNA Interactions","volume":"13","author":"Zhang","year":"20212021","journal-title":"Interdiscip. Sci. Comput. Life Sci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12943-017-0670-3","article-title":"Recent Advances in the Use of PI3K Inhibitors for Glioblastoma Multiforme: Current Preclinical and Clinical Development","volume":"16","author":"Zhao","year":"2017","journal-title":"Mol. Cancer"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3390\/molecules24091714","article-title":"Revealing Drug-Target Interactions with Computational Models and Algorithms","volume":"24","author":"Zhou","year":"2019","journal-title":"Molecules"},{"key":"B61","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1016\/j.ygeno.2020.07.044","article-title":"Probing Antiviral Drugs against SARS-CoV-2 through Virus-Drug Association Prediction Based on the KATZ Method","volume":"112","author":"Zhou","year":"2020","journal-title":"Genomics"},{"key":"B62","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s11658-019-0164-y","article-title":"Progress in Research on Paclitaxel and Tumor Immunotherapy","volume":"24","author":"Zhu","year":"2019","journal-title":"Cell Mol Biol Lett"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.832627\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T04:12:40Z","timestamp":1642479160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.832627\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":62,"alternative-id":["10.3389\/fgene.2021.832627"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2021.832627","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,17]]},"article-number":"832627"}}